first results of the soap project - max planck society

project-soap.eu

First results of the SOAP Project (What 40’000 scientists think of you)

COASP | 2nd Conference on Open Access Scholarly Publishing | Prague | 22-24 August 2010

Suenje Dallmeier-Tiessen, Bettina Goerner, Robert Darby, Jenni Hyppoelae, Peter Igo-Kemenes, Deborah Kahn, Simon Lambert, Anja Lengenfelder,

Chris Leonard, Salvatore Mele, Panayiota Polydoratou, David Ross, Sergio Ruiz-Perez, Ralf Schimmer, Mark Swaisland and Wim van der Stelt

BMC, CERN, MPDL, SAGE, Springer, STFC

Presented by Salvatore Mele/CERN, SOAP project co-ordinator

Outline

•  About the project •  Highlights from a study of OA journals today •  Results from a large-scale survey •  How can you help… (…this afternoon at 17:15!)

Salvatore Mele | CERN 2 COASP - Prague - August 23rd, 2010

Outline



SOAP Study of Open Access Publishing

•  Funded by the European Commission •  Framework Program 7 – Science and Society •  Scheduled to run from March 2009 to February 2011 •  Compare and contrast supply/demand for OA publishing •  Publishers, Libraries, Funding Agencies


Outline



A study of OA journals today

•  Assess the supply of OA publishing outlets today •  Start from the DOAJ •  Collect additional information

–  SCOPUS, ISI-JCR, EZB, SCImago, ask friends and colleagues –  Trawl through thousands of web pages

•  Answer key questions –  How many articles, journals, publishers? –  In which discipline, with which license? –  Where does the money come from? –  …

•  Some highlights in the following pages Salvatore Mele | CERN 6 COASP - Prague - August 23rd, 2010

How many?

•  English language journals •  90% of publishers <100 articles/year and 1/3 of total •  10% of publishers publish 2/3 of the total •  14 “large publishers”:

-  40K articles/year in 616 journals, 30% of the total -  6 commercial, 6 no-profit, 2 N/A


The 14 “large” publishers >1000 articles or >50 journals


!"#$%&'()*+,-(* ./")+,$&* 0)1%2$(&34(,)* !"#$%&'()*145(*

6%/7(8*9(+1),$* :;<* =>??@* 5"#$%&'%+A*'/"&(*2/--()2%,$*

B+1()+,1%/+,$*C+%/+*/D*9)4&1,$$/A),5'4* :* E>:<E* /1'()*+/+F5)/D%1*

!"#$%2*G%#),)4*/D*H2%(+2(* ;* I>@<=* 5"#$%&'%+A*'/"&(*+/+F5)/D%1*

0&%,+*J(1K/)L*D/)*H2%(+1%D%2*B+D/)-,1%/+* :@* M>E:I* 5"#$%&'%+A*'/"&(*2/--()2%,$*

N%+8,K%*!"#$%&'%+A*9/)5/),1%/+* =E* M>OII* 5"#$%&'%+A*'/"&(*2/--()2%,$*

9/5()+%2"&*!"#$%2,1%/+&* :=* M>O:M* 5"#$%&'%+A*'/"&(*+/+F5)/D%1*

P51%2,$*H/2%(14*/D*0-()%2,** :* :>?<:* $(,)+(8*&/2%(14*+/+F5)/D%1*Q/)$8*02,8(-4*/D*H2%(+2(>*R+A%+(()%+A*,+8*S(2'+/$/A4* :=* :>?<O* /1'()*J30*

6(+1',-*P5(+* :EI* :><<@* 5"#$%&'%+A*'/"&(*2/--()2%,$*

7(8L+/K*!"#$%2,1%/+&* E?* :>E;I* 5"#$%&'%+A*'/"&(*2/--()2%,$*

B+8%,+*02,8(-4*/D*H2%(+2(&* :O* :>:EM* $(,)+(8*&/2%(14*+/+F5)/D%1*

PTD/)8*C+%U()&%14*!)(&&* M* :>O@M* /1'()*+/+F5)/D%1*

02,8(-%2*./")+,$&* :O* :>OO:* 5"#$%&'%+A*'/"&(*J30*

B+1()+(1*H2%(+1%D%2*!"#$%2,1%/+&* <M* <E;* 5"#$%&'%+A*'/"&(*2/--()2%,$*!

About what?

•  2/3 of journals in STM; 1/3 in SSH •  3/4 of articles in STM; 1/4 in SSH •  “Large publisher” almost exclusively STM


Licensing practices

•  1/2 of “Large” publishers use Creative Commons •  82% CC-by, 18% CC-by-nc •  72% of journals, 71% of articles

•  “Other” publishers •  73% only with available information •  21% use some CC version •  10% state “authors retains copyright”


Presence of income sources NB – No information on income amount


Jour

nals

with

that

inco

me

sour

ce

Large publishers Other publishers

APC Membership

Advertisement

Sponsorship

Subscription

Hard copies

Outline



•  23 Questions •  Available at http://surveymonkey.com/soap_survey_g •  Live since 3 months

•  Dissemination through: - SOAP partners and contacts - Library mailing lists, SPARC-Europe, LIBER - Many, many, many publishers - OASPA ! You were wonderful! Thanks!

•  Estimate dissemination to >1.5 million people Salvatore Mele | CERN 13 COASP - Prague - August 23rd, 2010

The SOAP survey


The SOAP survey

!"#$""

!%#&$'

"#"($"#")*

!#&($

!"#$%&

'

!'#'''

%'#'''

$'#'''

*'#'''

('#'''

' ! % $

'()*+,-)+./01.+.2-3(4(5678*+-784+-98.7)8:(7801

';<=

>80?+9-@+17)65

'/)81A+)

B7C+)

=@DE)0F+37.

GBG;H

?BIGJ'

Are you involved in research?


How many articles have you published ?


38’358

Today: published researchers


Who ? Beliefs Actions

Preliminary results


Who ? - Demographics

Beliefs - Likes OA? Why? Why not?

Actions - Publishes OA? Why not? - Who pays? How? How easy?

Preliminary results



Preliminary results


Demographics


Distribution by country


Distribution by disciplines



Preliminary results


No large differences according to seniority and number of articles

Would OA journals be beneficial for your field?


!"#

#$%##

&$%&#

!%$&'&

( )((( &(((( &)((( #(((( #)((( !(((( !)((( %((((

*+,-./0+1234

*+,-./0+5.-6

7-

849

:%;<

:'";<

:=;<

:&;<

Why?

>22’000 answers, 1/2 million words


Why yes? (Only 14% read so far)


!"#

"$#

%&#

%$#

'#

"#

(# %(# "(# !(# '(#

)*+,-.)/01234-56,5713-**8/)369)-/

633:5:,69:123):/3:

633:22);)5)97

8/).:,2651633:22

-94:,

<)/6/3)651)228:2

Why not? (n=1005)


!"#

"$#

"%#

"&#

""#

$#

'#

(#

&#

)# (# ")# "(# !)# !(#

*+,-./0*123

4+2-455656

785954:5-+8-0;+/42-+<-<559

+2=58

<0184599>-?04123-78599

/49/920140@*5-<+8-7/@*19=14AB9+:152159

4+-+8-@06-7558C85?15,

A8554-+0-19-54+/A=

78+<12-681?54



By country

!"#$%#

$&#$&#$&#

$'#$!#$!#$!#$$#$$#$$#$$#$$#$$#$$#$"#$"#"(#"(#"(#"(#"(#"(#

"%#"%#"%#

")#"*#"*#

+,-./0112-345-.67-28-.9-:-.70,;<=+1,-<5

>[email protected]

B<.C-,;D,-.E<

F01G,-52->HF

@-.-6-?4,<-IJH40GA

F01G,2-H2.K-:4,<L<5K20C

+G-5=M<GA<,5-.61

N<,C-.=H82GO<,5-.6

H:-2.H8<6<.N,<<E<D2.5-.6+.62-L,-O25

34,G0K-5P<Q2E4



Yes

!"#$

%"&$

%"'$

%"($

%"#$

&"%$

&"&$

&"&$

&"&$

&")$

&")$

&")$

&"*$

+"&$

+",$

+",$

+",$

+")$

+")$

,"!$

,"!$

,"!$

,"%$

,"+$

,"*$

'"!$

'"%$

'"#$

)"&$

)"*$

-./012342/567891:434.;<=/2

>./5>561/?@15/A<.B8CD152/56E.88:8FG/15

H4.8/IJF4<;@A/1K/5L<MM1/

F15=/G4.8N/G/5>;/2C

D./5:8-82=1<O

P8;@8.2/56M>M./82

FK1;08.2/56FK8685

E8.O/5CQFR

?/5/6/R<M;.1/

R<M;./21/S85O/.B

QH



No

!"#$

!"%$

&"#$

&"'$

&"'$

#"($

#")$

#"*$

#"!$

#"&$

#"&$

#"%$

#"+$

#",$

%"($

%"($

%"*$

%"*$

%"&$

%"#$

'"*$

'"&$

+"!$

+"!$

)(",$

)(",$

))")$

)*"+$

)#"'$

)'",$

-./012

32456789

:6;5408

<.4=8>?

@.>=84A

BC

D0>98>E

:6;548908

FG05H.498>E

I.5J.498>E;

K48H09

FG.E.>

L>E08

F0>78M24.

BF:

L589?

N8>8E8

<4..1.

FM80>

K.9706=

D48>1.

C24.8OPF265J

L;48.9

NJ0>8

Q64A.?

R8M8>

Q80G8>

S6;;08

3298>E

L48>



No opinion

!"#$!"#$!"%$

!"&$!"&$

!"'$!"'$!"($!")$!")$

!"*$!"*$!"*$+"!$

+"+$+"+$+"#$+"#$+"%$+"%$+"%$+",$+",$

+"'$+"($

#"!$#"+$

%"!$%",$

,"#$

-./0/123//4/536789

5/9:8;<=61606

>1086-.8?7/39610

-@681A;B?36986C/D84E

F/?G/39610BH-A

IE3?;:69>?69JHK

>B36/9L/1<63MN3614/

>361N819610

2/3<61JO;3M/JIE9610

KE3/6PQ-E;?G-81:6@E3/

A;B?386=G816R;[email protected]



I do not care



By field

!!"

#$"

#$"

#%"

#&"

#!"

#'"

#'"

'("

'("

'("

')"

')"

'$"

'$"

'$"

'*"

'*"

'%"

+,-./0123

4012565.3786970:8;-70;/-6;-

<,30/;0786972-=81-970;/-6;-0

>6?/6--2/6?786971-;,65=5?3

42;,/1-;1@2-A7B@/=9/6?78697:=866/6?

C81,-.81/;8=78697;5.:@1-270;/-6;-0

4?2/;@=1@2-786972-=81-970;/-6;-0

>821,70;/-6;-0

D@0/6-007869789./6/01281/E-701@9/-0

<03;,5=5?3

F8G

D/5=5?/;8=70;/-6;-0

+2-81/E-78210786979-0/?6

C-9/;/6-A79-61/0123A72-=H70@BI-;10

J5;/8=70;/-6;-0

K/0152/;8=78697:,/=505:,/;8=701@9/-0

>9@;81/56

C8007+5..@6/;81/56078697L5;H

F86?@8?-78697=/1-281@2-701@9/-0



Yes

!"!#!"$#!"%#!"&#!"&#'"!#'"'#'"(#'"%#'"&#

)"'#)")#)"*#)"(#

*"+#("'#

("+#%"&#

+"!#

,-./0-/12-.3245617-6071286035189/75:0460712-.32714-61328:51.:18

97:;561:6071<2=05435./2-.32>4-..5./[email protected]:-65A.82-.32CA:"

D30:[email protected]/.

FA:5-428:51.:18,-G

?135:5.1<231.65867H<2714"280=I1:68J586A75:-42-.32>;54A8A>;5:-428603518

K5A4A/5:-428:51.:18K085.1882-.32-3B5.5867-65E128603518

D-76;28:51.:18L8H:;A4A/H

D./5.1175./2-.3261:;.A4A/H?-6;1B-65:-42-.32:AB>061728:51.:18

L;H85:82-.32714-61328:51.:189867A.ABH2-.328>-:128:51.:1

@;1B5867H



No

!"#$

!"%$

&"&$

&"'$

&"($

'")$

'"&$

'"#$

'"%$

*"+$

*"!$

*"($

#",$

%"+$

%"&$

%"($

("!$

++"%$

+)"+$

-.//012334567.8625/0.590:27"

;.5<4.<=0.590>68=?.84?=0/8496=/

@6/82?67.>0.590AB6>2/2AB67.>0/8496=/

C62>2<67.>0/76=57=/

D947.8625

-=96765=E09=586/8?FE0?=>"0/4GH=78/

I276.>0/76=57=/

1?=.86J=0.?8/0.5909=/6<5

K/F7B2>2<F

D.?8B0/76=57=/

C4/65=//0.590.93656/8?.86J=0/8496=/

;.L

-.8B=3.867.>0.590723A48=?0/76=57=/

M/8?2523F0.590/A.7=0/76=57=

M<?674>84?=0.590?=>.8=90/76=57=/

D5<65==?65<0.5908=7B52>2<F

KBF/67/0.590?=>.8=90/76=57=/

M?7B68=784?=E0G46>965<0.590A>.5565<

1B=36/8?F



No opinion

!"#$!"%$!"%$!"%$!"&$!"'$!"'$!"($!"($!")$!"*$#"!$

#"#$#"+$#"+$

#"'$#"*$

+"#$+"&$

,-./0-/12-.3245617-607128603518930:-65;.

<586;75:-42-.32=>54;8;=>5:-428603518?7:>561:6071@2A05435./2-.32=4-..5./

,-BC135:[email protected]@2714"280AE1:68

F085.1882-.32-3G5.5867-65H128603518I8D:>;4;/D

J71-65H12-7682-.323185/.K;:5-428:51.:18

F5;4;/5:-428:51.:18?/75:0460712-.32714-61328:51.:18

9-76>28:51.:18C-6>1G-65:-42-.32:;G=061728:51.:18

C-882J;GG0.5:-65;.82-.32L;:"9./5.1175./2-.3261:>.;4;/D

J>1G5867D?867;.;GD2-.328=-:128:51.:1I>D85:82-.32714-61328:51.:18



I do not care

Beliefs about OA – positive

Publicly-funded research should be made available to be read and used without access barrier

1.5 2.2

Researchers should retain the rights to their published work and allow it to be used by others

2.0 2.2

Articles that are available by OA are likely to be read and cited more often than those not OA

2.1 3.0

1 Strongly agree; 2 Neutral; 3 Disagree; 4 Strongly disagree


Would OA journal be beneficial? Yes Negative

Open Access publishing is more cost-effective than subscriptions and will benefit public investment in research

2.4 3.1

If authors pay OA publication fees there will be less money available for research

2.6 2.3

OA unfairly penalises research-intensive institutions with large publication output by making them pay high costs for publication

3.0 2.6



Beliefs about OA – neutral


Open Access publishing leads to an increase in the publication of poor quality research

3.6 2.7

Open Access publishing undermines the system of peer review

3.8 2.9

It is not beneficial for the general public to have access to published scientific and medical articles

4.0 3.4



Beliefs about OA – negative



Preliminary results


How many OA articles have you published in the last 5 years?


!"

#!"

$%"

&"

%"

'" #'" ('" &'"

)*+,*-,.*/-,0

'

12$

&21'

3,45*.67-*1'

How many OA articles have you published in the last 5 years?


!" #!" $!" %!" &!" '!" (!" )!"

*+,-.-/+01,+/2-3245014+671389:+.23

;-<6<=-.>613.-+/.+3

?4+>2-@+1>4231>/,1,+3-=/

*>331.<AA8/-.>2-</31>/,1,<.8A+/2>2-</

B=4-.86284+1>/,14+6>2+,13.-+/.+3

C>D

E,8.>2-</

E>42F13.-+/.+3

C>/=8>=+1>/,16-2+4>284+1328,-+3

GF53-.31>/,14+6>2+,13.-+/.+3

H<.->613.-+/.+3

*>2F+A>2-.>61>/,1.<AI82+413.-+/.+3

J-32<4-.>61>/,1IF-6<3<IF-.>61328,-+3

B4.F-2+.284+0198-6,-/=1>/,1I6>//-/=

G35.F<6<=5

;83-/+331>/,1>,A-/-324>2-@+1328,-+3

?F+A-3245

E/=-/++4-/=1>/,12+.F/<6<=5

B324</<A51>/,13I>.+13.-+/.+

!

#12<1'

(12<1#!

*<4+12F>/1#!

!"#

$%#

"#

"#

&#

'#

$#

(# )(# $(# !(# *(# +(#

,-./0.1

23456014

76843

89:065

-.9;934.455<01.739.=4

.41960>4?4@24304.=4

A.4@6?60B4A

Was there a reason not to publish OA?

42% have a reason; >4000 answers; 60’000 words


Which fee did you pay for your last OA article?


!"#$%

&#$%

'#"%

($#'%

)#)%

"#$%

(*#"%

"#"% $"#"% *"#"% '"#"%

+,-./0123

45-6,- $!"-789!":

$!(; !""-789!";8&"":

!"(; ("""-78&"";8(9!":

(""(; 9"""-78(9!";8*("":

<,13-6/0=- 9"""-78*("":

>-?,-=,6-@=,A

How was this fee covered?


!!"

#$#%"

&$'()

&$""&

&$))"

*(+,

*#&+,

*&!+,

*'#+,

*&-+,

. #$... &$... '$... !$...

/0123

4567895:;<2=>

?;58@<080A08B@56789

C2<273D15>A@98@E5@B058@02@929

C2<273D15>A@98@E58@D=A92<



By field

How was this fee covered? Included in research funds


!"#

!"#

!$#

!$#

%&#

%'#

%"#

%"#

%(#

%!#

%%#

%)#

*'#

*+#

*+#

*"#

*$#

)# *)# %)# !)# $)#

,-./0123456352

72/.8689:1-6;12<-3512345635

=0:24321-6;1.5>-/5;123456352

?48>8@43->123456352

,[email protected]@1-6;1/53068>8@:

A05942/.:

B42/8.43->1-6;1<04>828<043->12/C;452

D-/059-/43->1-6;1389<C/5.123456352

[email protected]>/C.51-6;1.5>-/5;123456352

E834->123456352

=2:308>8@:

D5;43465F1;56/42/.:1-6;1.5>-/5;12CGH53/2

?C2465221-6;1-;94642/.-/4I512/C;452

,;C3-/486

D-2213899C643-/48621-6;1;83C956/-/486

7.304/53/C.5F1GC4>;46@1-6;1<>-6646@

J-6@C-@51-6;1>4/5.-/C.512/C;452

How was this fee covered? Used other part of research funds


!"#

!$#

!$#

!%#

!&#

$'#

$'#

$(#

$(#

$(#

$)#

$"#

%'#

%"#

%!#

%$#

%%#

&# %&# $&# !&# "&#

*+,-,.+/0-12/+34/3256/7+83/8963:1;9+-<+4.104<1=-044+4.

>3<+/+43:1<348+286?104<163-083<1>0873@08+/0-104<1/,@=983612/+34/32

A73@+286?B2?/7,-,.?

C4.+4336+4.104<183/74,-,.?C068712/+34/32

5.6+/9-8963104<163-083<12/+34/32>0221/,@@94+/08+,42104<1

B7?2+/2104<163-083<12/+34/32D,/+0-12/+34/32

E+28,6+/0-104<1=7+-,2,=7+/0-1289<+32F04.90.3104<1-+836089631289<+325286,4,@?104<12=0/312/+34/3

C<9/08+,4*92+4322104<10<@+4+28608+G31289<+32

How was this fee covered? My institution paid


!"#

!"#

!$#

!$#

!%#

!%#

!%#

!%#

!%#

!&#

!&#

!!#

!!#

!'#

!(#

'$#

'$#

(# '(# !(# &(#

)*+,-.-/012.31*42561*576.56863757.69136.+7*+,012.31,6:2+631*;<=65+*

>-572:1*576.56*?2,+@1*576.56*

?3;52+7-.82+@6/2+752:12.315-/4;+6,1*576.56*

)A,75;:+;,612.31,6:2+631*576.56*B@0*75*12.31,6:2+631*576.56*?.A7.66,[email protected]:-A0

82**15-//;.752+7-.*12.313-5;/6.+2+7-.C7*+-,752:12.314@7:-*-4@752:1*+;376*D;*7.6**12.3123/7.7*+,2+7E61*+;376*

D7-:-A752:1*576.56*B*05@-:-A0F@6/7*+,0

G2.A;2A612.31:7+6,2+;,61*+;376*),5@7+65+;,691<;7:37.A12.314:2..7.A

How was this fee covered? I paid myself


!"#

!$#

!%#

$&#

$'#

$'#

$$#

$%#

("#

("#

()#

()#

()#

('#

*#

*#

"#

%# (%# $%# '%# !%# )%#

+,-./,.01,-2134506,5/60175/2407

82/9,54:-

;/74-0771,-21,2<4-4756,54=0175/2407

>69?45095/60@1A/4324-.1,-21B3,--4-.

C,7719:<</-49,54:-71,-212:9/<0-5,54:-

D475:649,31,-21B?43:7:B?49,3175/2407

E:94,317940-907

F7G9?:3:.G

>.649/35/601,-21603,50217940-907

C02494-0@120-54756G1,-21603,50217/AH0957

I?0<4756G

8-.4-0064-.1,-21509?-:3:.G

>756:-:<G1,-217B,9017940-90

C,5?0<,549,31,-219:<B/50617940-907

F?G74971,-21603,50217940-907

8,65?17940-907

;4:3:.49,317940-907



By country


Included in research funds



Used other part of research funds



My institution paid



I paid myself


How easy was it to obtain funds?


!"#$%

$"$$&

#"%#'

(!%)*

(%$)*

(&!)*

' !"''' #"''' &"''' $"''' %"'''

+,-./012

345546/7-

890:



!" #!" $!" %!" &!" '!" (!" )!" *!" +!" #!!"

,-../.01-2.341556789:67

;.<6/=8-79

>15?-7@67A=-?1B7@

C-7D6@8?7@385-7.@

EF.:.9A=@79:EG769

HIJ797:7K-79/.

[email protected]

JN697HE>

K69@79:E69B7G=-.

O.?N.-@79:5EF6?D.-@79:

076F79,.-L793>15?-67

I=-.7PQE=1?NR7G79

S753

M6TT6/1@?

8QN7U.Q9=?Q15.:Q?N.5.Q5=1-/.5



!" #!" $!" %!" &!" '!" (!" )!" *!"

+,-./012345241

6,./47,.32,80,5902:7;<.4-012345241

=/>13210,590-48,.49012345241

?31.:-32,80,590;/38:1:;/32,801.<9341

@1.-:5:7>0,5901;,2401234524

A3:8:B32,8012345241

@B-32<8.<-40,590-48,.49012345241

6,1102:77<532,.3:510,5909:2<745.,.3:5

+5B3544-35B0,590.42/5:8:B>

+9<2,.3:5

C/4731.->

64932354D0945.31.->0,590-48,.4901<EF42.1

G:23,8012345241

A<1354110,590,973531.-,.3H401.<9341

=1>2/:8:B>

@-2/3.42.<-4D0E<38935B0,590;8,5535B

C-4,[email protected],590I413B5

J,5B<,B40,59083.4-,.<-401.<9341

+,1>

I3KK32<8.

L0/,H405:.0<1490./41401:<-241


Conclusions

•  Strive to provide facts on which to base decisions (EC, publishers, libraries, funding agencies)

•  Just scratched the surface of the survey so far •  More questions on drivers/barriers in publishing •  17’000 scientists left e-mail for further contact •  Need to understand what to ask more…

…to the data …to the volunteers

Outline



project-soap.eu

Thank you!

•  Project team: [email protected] •  Speaker: [email protected] •  Website: http://soap-fp7.eu •  SOAP workshop Berlin, January 13th, 2011(after APE) http://soap-fp7.eu/final-workshop

first results of the soap project - max planck society

Documents